DD153192A5 - Verfahren zur herstellung eines immunobiotherapeutischen arzneipraeparates - Google Patents

Verfahren zur herstellung eines immunobiotherapeutischen arzneipraeparates Download PDF

Info

Publication number
DD153192A5
DD153192A5 DD222593A DD22259380A DD153192A5 DD 153192 A5 DD153192 A5 DD 153192A5 DD 222593 A DD222593 A DD 222593A DD 22259380 A DD22259380 A DD 22259380A DD 153192 A5 DD153192 A5 DD 153192A5
Authority
DD
German Democratic Republic
Prior art keywords
nctc
strains
lysate
item
sodium
Prior art date
Application number
DD222593A
Other languages
German (de)
English (en)
Inventor
Farine
Rivkine
Bulto
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of DD153192A5 publication Critical patent/DD153192A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD222593A 1979-07-26 1980-07-14 Verfahren zur herstellung eines immunobiotherapeutischen arzneipraeparates DD153192A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH692479A CH639852A5 (fr) 1979-07-26 1979-07-26 Medicament contre les maladies infectieuses des voies urinaires et digestives.

Publications (1)

Publication Number Publication Date
DD153192A5 true DD153192A5 (de) 1981-12-30

Family

ID=4317195

Family Applications (1)

Application Number Title Priority Date Filing Date
DD222593A DD153192A5 (de) 1979-07-26 1980-07-14 Verfahren zur herstellung eines immunobiotherapeutischen arzneipraeparates

Country Status (16)

Country Link
JP (1) JPS5622733A (xx)
AR (1) AR222887A1 (xx)
BE (1) BE884456A (xx)
CH (1) CH639852A5 (xx)
CS (1) CS212234B2 (xx)
DD (1) DD153192A5 (xx)
DE (1) DE3019448A1 (xx)
ES (1) ES491920A0 (xx)
FR (1) FR2462164A1 (xx)
GB (1) GB2054374B (xx)
HU (1) HU181725B (xx)
IT (1) IT1143025B (xx)
PL (1) PL127520B1 (xx)
PT (1) PT71612A (xx)
RO (1) RO80054A (xx)
YU (1) YU42532B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707B1 (fr) * 1983-08-17 1986-02-28 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
EP2345421A1 (en) 2003-06-23 2011-07-20 Biotech Tools S.A. Epitope composition for sublingual or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
SI2117587T1 (en) * 2007-03-05 2018-04-30 Om Pharma Bacterial extract for disorders of the digestive or urinary tract and the process for its preparation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336015A (en) * 1970-06-03 1973-11-07 Unilever Ltd Rearing pigs
US3911109A (en) * 1971-10-14 1975-10-07 Lever Brothers Ltd Rearing calves
BE789864A (fr) * 1971-10-14 1973-04-09 Unilever Nv Elevage des veaux
JPS5219927B2 (xx) * 1972-06-08 1977-05-31
GB1462384A (en) * 1973-04-12 1977-01-26 Unilever Ltd Rearing of lambs
GB1560934A (en) * 1975-05-07 1980-02-13 Unilever Ltd Methods for the resistance of non-human mammals to gastro-intestinal disorders
US4141970A (en) * 1975-05-07 1979-02-27 Internationale Octrooimaatschappij "Octropa" B.V. Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections
US4136167A (en) * 1975-06-12 1979-01-23 Internationale Octrooi Maatschappij "Octropa" B.V. Process for reducing the incidence of neonatal diarrhoea in pigs
GB1581776A (en) * 1976-08-18 1980-12-17 Smith Kline Rit Vaccines against oedema disease of piglets

Also Published As

Publication number Publication date
DE3019448A1 (de) 1981-02-12
YU189680A (en) 1983-06-30
GB2054374B (en) 1983-06-22
JPH0255407B2 (xx) 1990-11-27
IT1143025B (it) 1986-10-22
GB2054374A (en) 1981-02-18
FR2462164B1 (xx) 1983-08-05
CS212234B2 (en) 1982-03-26
YU42532B (en) 1988-10-31
AR222887A1 (es) 1981-06-30
HU181725B (en) 1983-11-28
ES8104402A1 (es) 1981-04-01
JPS5622733A (en) 1981-03-03
CH639852A5 (fr) 1983-12-15
DE3019448C2 (xx) 1987-07-30
IT8049314A0 (it) 1980-07-24
ES491920A0 (es) 1981-04-01
PL225853A1 (xx) 1981-05-08
FR2462164A1 (fr) 1981-02-13
BE884456A (fr) 1980-11-17
PT71612A (fr) 1980-08-01
RO80054A (ro) 1982-10-26
PL127520B1 (en) 1983-11-30

Similar Documents

Publication Publication Date Title
DE2813733C2 (xx)
DE69226622T2 (de) Lyophilisierte Bakterien enthaltende Diät- oder Arzneimittelnzusammenstellungen
DE69424112T2 (de) Verfahren zur Herstellung von Iturin A und Fungizid für schwere Mycosis
DE3205018A1 (de) Bifidobakterien vermehrendes mittel
CH627348A5 (de) Verfahren zur herstellung fermentierter, lebensfaehiger bifidobakterien enthaltender milch und verwendung der so erhaltenen milch.
EP2358642B2 (de) Klinoptilolith oder klinoptilolithhaltige gemische
DE1492135A1 (de) Verfahren zur Herstellung von Medikamenten fuer die Regenerierung der Darmmikroflora
DD153192A5 (de) Verfahren zur herstellung eines immunobiotherapeutischen arzneipraeparates
DE69028520T2 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
DE2917730C2 (de) Immunobiotherapeutisches Arzneipräparat gegen Infektionen der Atemwege und Verfahren zu seiner Herstellung
KR0169982B1 (ko) 피부염 치료용 약제
EP1894995B1 (de) Irilis-biopräparation auf der basis von darin enthaltenen bacillus-bakterienstämmen bacillus subtilis und bacillus licheniformis
DE3035193A1 (de) Neues antibiotikum sf-1130-x(pfeil abwaerts)3(pfeil abwaerts), verfahren zur herstellung desselben sowie mittel, welche das neue antibiotikum
DD222895A5 (de) Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids
DE3118148A1 (de) Antiallergisches praeparat und verfahren zu seiner herstellung
EP0173950A2 (de) Neuer alpha-Glukosidase Inhibitor, Verfahren zur seiner Herstellung, seine Verwendung und pharmazeutische Präparate
DE69122186T2 (de) Laktobazillus acidophilus-f-133, herstellung von davon ausgehenden milchsäurebakterien und verfahren zu deren herstellung
DE2106154A1 (en) Antibiotic - resistans streptococcus faecalis - for treatment and prophylaxis of digestive disturbances
TW570800B (en) Agents protective against hepatopathy
DE2737943A1 (de) Neue antibiotika, substanzen sf-1130- x tief 1 und -x tief 2 , verfahren zu ihrer herstellung und ihre verwendung
DE3147311C2 (xx)
DE2833014A1 (de) Antibiotisch wirksames mittel
DD232167A3 (de) Verfahren zur herstellung von androstanderivaten
AT230541B (de) Verfahren zur Herstellung mikrobieller Stoffwechselprodukte mit organspezifischer Wirkung
EP0173948A2 (de) Neue Pseudooligosaccharide mit alpha-Glukosidase-hemmender Wirkung, Verfahren zur deren Herstellung, deren Verwendung und pharmazeutische Präparate

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee